Filter
5192
Filtered Results: 5192
Text search:
severe
infections
Featured
Recommendations
624
New Publications
1243
Language
Document type
No document type
2601
Guidelines
905
Studies & Reports
801
Manuals
252
Fact sheets
211
Strategic & Response Plan
195
Training Material
105
Situation Updates
55
Infographics
19
Resource Platforms
14
Brochures
13
Online Courses
12
Dashboards/Maps
4
Videos
4
App
1
Countries / Regions
India
288
Global
201
Kenya
119
South Africa
114
Sierra Leone
108
Liberia
108
Ethiopia
108
Western and Central Europe
94
Latin America and the Carribbean
88
Uganda
86
Nigeria
84
Africa
82
Nepal
79
Rwanda
71
Malawi
69
Syria
63
Tanzania
63
Bangladesh
62
Myanmar / Burma
55
West and Central Africa
55
Russia
53
Brazil
51
Mozambique
50
Ghana
48
Zambia
48
Middle East and North Africa
48
East and Southern Africa
47
Philippines
44
South–East Asia Region
41
Congo, Democratic Republic of
39
Ukraine
38
Zimbabwe
36
Haiti
36
South Sudan
36
Guinea
32
Namibia
30
Lesotho
29
Yemen
29
Eastern Europe
27
Germany
25
Indonesia
25
Cambodia
24
Senegal
23
Eastern Europe and Central Asia
23
Burkina Faso
21
Asia
20
Western Pacific Region
18
Venezuela
18
Angola
16
USA
14
Eswatini/ Swaziland
14
Colombia
14
Pakistan
13
Cameroon
12
Afghanistan
12
Peru
11
Botswana
11
Vietnam
11
Guinea-Bissau
10
Somalia
10
Sudan
10
Iraq
9
Turkey
9
Central African Republic
9
Madagascar
8
Chile
8
Spain
8
Thailand
7
Albania
7
Saudi Arabia
6
Jordan
6
Lebanon
6
China
6
Italy
6
Tajikistan
6
United Kingdom
6
Mali
5
Ecuador
5
Bolivia
5
Mexico
5
Palestine
5
Moldova
5
Georgia
5
Côte d’Ivoire / Ivory Coast
4
Niger
4
Papua New Guinea
4
Benin
4
Argentina
4
Southern Africa
4
France
4
Portugal
4
Egypt
3
Chad
3
Gambia
3
North Macedonia
3
Greece
3
Sri Lanka
3
Laos
3
Timor Leste/ East Timor
3
Iran
3
Kazakhstan
3
Turkmenistan
3
Morocco
2
Togo
2
Singapore
2
Serbia
2
Burundi
2
Other region
2
Paraguay
2
Fiji
2
Uzbekistan
2
North America
2
Mauritius
2
Malaysia
1
Dominican Republic
1
Austria
1
Switzerland
1
Honduras
1
El Salvador
1
Libya
1
Nicaragua
1
Solomon Islands
1
Bhutan
1
Djibouti
1
Armenia
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Bulgaria
1
Kyrgyzstan
1
Australia
1
Jamaica
1
Denmark
1
Tunisia
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2004
Clinical Guidelines
569
Women & Child Health
336
Public Health
232
Key Resources
165
Capacity Building
113
Pharmacy & Technologies
47
Annual Report MEDBOX
2
Toolboxes
COVID-19
972
HIV
315
TB
287
Mental Health
216
Rapid Response
208
Ebola
192
NTDs
175
Caregiver
140
AMR
136
Planetary Health
136
Conflict
112
Disability
104
Refugee
89
NCDs
85
Pharmacy
72
Cholera
55
Natural Hazards
55
Zika
51
Global Health Education
50
Health Financing Toolbox
29
Specific Hazards
27
Polio
22
South Sudan
2
Typhoon
2
Social Ethics
1
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particul...
Данный курс предназначен для практикующих врачей, работающих в отделениях реанимации и интенсивной терапии (ОРИТ) в странах с низким и средним уровнем дохода, а та...
Mycetoma is a slow-growing bacterial or fungal infection, most often of the foot, that may spread to other parts of the body and can cause severe deformity. It is a debilitating disease that most of...
JAMA. Published online July 14, 2020. doi:10.1001/jama.2020.13107
In this issue of JAMA, Wang, et al. present evidence that universal masking of healthcare workers (HCWs) and patients can help reduce transmission of severe acute respiratory syndro...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of info...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by th...
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted ... (chlamydia) and disease in lymph nodes.
This is photomicrograph of a conjunctival smear that revealed the presence of what are known as, intracytoplasmic inclusions Trachoma is easily spread through direct personal contact such as from fingers, through shared towels and clothes, and through flies that have been in contact with the eyes or nose of an infected person. When left untreated, repeated Chlamydia trachomatis infections in the eye can cause severe scarring on the inside of the eyelid. This can cause the eyelashes to scratch the cornea (trichiasis). In addition to causing pain, trichiasis permanently damages the cornea and can lead to irreversible blindness.
Chlamydia trachomatis infections spread in areas that lack access to safely managed drinking water and sanitation systems. Trachoma affects the most resource-limited communities in the world. Globally, almost 1.9 million people have vision loss because of trachoma, and it causes 1.4% of all blindness worldwide.1 In 2021, 136 million people lived in trachoma-endemic areas and were at risk of trachoma blindness.
Public health surveillance for COVID-19: interim guidance 16 December 2020 (Arab Version)
recommended
This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2...
This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2...
Elderly people are at a higher risk of COVID-19 infection due to their decreased immunity and body reserves, as well as multiple associated comorbidities like diabetes, hypertension, chronic kidney disease and chronic obstructive pulmonary disease. ...
Le COVID-19 est un nouveau coronavirus, proche de celui du Syndrome Respiratoire Aigu Sévère (SRAS) qui avait été à l’origine d’une épidémie meurtrière en 2003. L’infection par ce nouv...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of ... illness and mortality from COVID-19 disease in comparison with non-pregnant women of reproductive age. As seen with non-pregnant women, a high proportion of pregnant women have asymptomatic SARS-CoV-2 infection and severe disease is associated with recognized medical (e.g., high body-mass index (BMI), diabetes, pre-existing pulmonary or cardiac conditions) and social (e.g., social deprivation, ethnicity) risk factors. Pregnant women with symptomatic COVID-19 appear to have an increased risk of intensive care unit admission, mechanical ventilation and death in comparison with non-pregnant women of reproductive age, although the absolute risks remain low. COVID-19 may increase the risk of preterm birth, compared with pregnant women without COVID-19, although the evidence is inconclusive.
COVID-19 is a pandemic that is currently ravaging the world. Infection rate is steadily increasingin Sub-Saharan Africa. Pregnant women and their infants may suffer severe illnesses due to theirlowe...
Antimicrobial Resistance Resource Platform
recommended
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
AMR occurs when bacteria, viruses, fungi and parasites change over time and ...
Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these ...
إرشاداتٌ حول إنشاء عنابر العزل الخاصة بالحالات المصابة بفيروس كورونا المستجد
This document simplifies the WHO guidance on severe acute respiratory ... (SARI) treatment centres and is meant to be accessible to healthcare workers, policymakers and others who want
a quick overview of the key requirements for a COVID-19 isolation centre either within an existing facility or as a standalone centre.
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infection... are potentially curable as long as the aetiological agents are susceptible to the antimicrobial drugs. The rapid rate with which antimicrobial agents are becoming ineffective due to resistance acquired as a result of unchecked overuse and misuse threatens to undo the benefit of controlling infections. The evidence for resistant microorganisms, many times to more than a single antimicrobial agent, has been observed globally. In Tanzania, there is evidence in the form of few scattered studies conducted in different parts of the country in a multitude of settings including health care facilities, the community, domesticated animals and wild animals
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome...
